What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
His primary areas of investigation include Melanin, Biochemistry, Molecular biology, Pigment and DNA damage.
His study in Melanin is interdisciplinary in nature, drawing from both Botany, Photochemistry, Hydrolysis, Tyrosinase and Human skin.
His work in Biochemistry tackles topics such as Coat which are related to areas like Solubilization.
His Molecular biology research is multidisciplinary, incorporating elements of DMBA, Allele, Melanocortin 1 receptor, Receptor and Ornithine decarboxylase.
His research integrates issues of Neuromelanin, Cysteine, Identification and Skin type in his study of Pigment.
Kazumasa Wakamatsu interconnects Adaptive response, Melanoma, Physiology and Antioxidant in the investigation of issues within DNA damage.
His most cited work include:
- Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter (517 citations)
- Chemistry of mixed melanogenesis--pivotal roles of dopaquinone. (308 citations)
- Quantitative Analysis of Eumelanin and Pheomelanin in Humans, Mice, and Other Animals: a Comparative Review (303 citations)
What are the main themes of his work throughout his whole career to date?
Kazumasa Wakamatsu mainly focuses on Melanin, Biochemistry, Tyrosinase, Melanoma and Internal medicine.
His Melanin research incorporates elements of Molecular biology, Pigment, Photochemistry and Melanocyte.
Kazumasa Wakamatsu works mostly in the field of Pigment, limiting it down to topics relating to Botany and, in certain cases, Feather.
His Tyrosinase study integrates concerns from other disciplines, such as Tyrosine, Cysteine, Cell biology, Cytotoxicity and Quinone.
His Melanoma research incorporates themes from Cell culture, Immunotherapy, Immunology and Pathology.
He focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Endocrinology and, in certain cases, Melanocortin 1 receptor.
He most often published in these fields:
- Melanin (38.77%)
- Biochemistry (20.00%)
- Tyrosinase (17.28%)
What were the highlights of his more recent work (between 2017-2021)?
- Melanin (38.77%)
- Melanosome (9.88%)
- Pigment (13.58%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Melanin, Melanosome, Pigment, Photochemistry and Tyrosinase.
His Melanin study contributes to a more complete understanding of Biochemistry.
His Biochemistry research focuses on Dopamine and how it connects with Neurodegeneration.
His Pigment research integrates issues from Zoology, DHICA and Botany.
His Photochemistry research focuses on Singlet oxygen and how it relates to Superoxide, Benzothiazole and Electron paramagnetic resonance.
The various areas that Kazumasa Wakamatsu examines in his Tyrosinase study include Catechol, Glutathione, Cysteine and Quinone.
Between 2017 and 2021, his most popular works were:
- Linking a mutation to survival in wild mice. (64 citations)
- Soft-tissue evidence for homeothermy and crypsis in a Jurassic ichthyosaur (31 citations)
- Photodegradation of Eumelanin and Pheomelanin and Its Pathophysiological Implications (25 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Gene
- Internal medicine
His scientific interests lie mostly in Melanosome, Evolutionary biology, Melanin, Taphonomy and Tyrosinase.
The Melanosome study combines topics in areas such as Exome sequencing, Photochemistry, Synchrotron, X-ray absorption spectroscopy and Morphology.
The Evolutionary biology study which covers Feather that intersects with Plumage and TYRP1.
Kazumasa Wakamatsu combines subjects such as Lipofuscin, Pathology, Albinism, Oculocutaneous albinism and Organelle with his study of Melanin.
Part of his project on Tyrosinase includes research on Enzyme and Biochemistry.
His Biochemistry study frequently draws connections to other fields, such as Leukoderma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
